Acromegaly Market Forecast 2025-2034: Growth Dynamics, Emerging Trends, and Strategic Opportunities
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Are the Primary Drivers Supporting the Market Growth of theAcromegaly Market?
The escalating rise in hormonal disorders such as diabetes is predicted to fuel the expansion of the acromegaly market in the future. Hormonal disorders, also termed endocrine disorders, are diseases arising from disfunction in the endocrine system. With diabetes being one of the most common and prominent hormonal disorders, acromegaly, along with other endocrine disorders, can be induced by an overproduction of certain hormones like growth hormone or cortisol. Moreover, around half of the individuals with acromegaly could develop insulin resistance or type 2 diabetes mellitus because of the influence of elevated levels of growth hormone on the synthesis of insulin. For example, as reported by the UK-based government department, the Office for Health Improvement and Disparities, in March 2024, from March 2022 to March 2023, the proportion of people with type 1 diabetes receiving all eight recommended care processes saw a surge of 22%, and a 21% rise for type 2 diabetes. Meanwhile, those attaining target HbA1c levels grew to 37.9% as per the National Diabetes Audit (NDA), marking the highest value ever recorded. Hence, the rising prevalence of hormonal disorders is fuelling the growth of the acromegaly market.
Acromegaly Market Driver: Influence of Genetic Abnormalities on Acromegaly Market Expansion
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12913&type=smp
What is the Predicted Annual Growth Rate of theAcromegaly Market Impact Industry Trends by 2034?
In the last few years, the market size of acromegaly has seen substantial expansion. The market is projected to increase from a $2.15 billion valuation in 2024 to $2.57 billion in 2025, experiencing a compound annual growth rate (CAGR) of 19.6%. This upsurge during the historic period can be tied to factors such as increased incidence of acromegaly therapeutics, heightened acromegaly awareness, governmental efforts, and the need for efficient treatments.
The market size of acromegaly is predicted to witness a swift expansion in the coming years. The market is anticipated to surge to $4.92 billion by 2029, growing at a compound annual growth rate (CAGR) of 17.6%. The increased growth in the projection period can be ascribed to the inflow of resources into research and development efforts for acromegaly cures, an upswing in the number of screening schemes, escalating healthcare expenditure, and a burgeoning demand for less invasive treatment alternatives. Key trends projected for the forecast period include groundbreaking acromegaly treatments, the formation of acromegaly targeted therapies, a robust pipeline of pharmaceuticals, progressions in treatment choices, and sophisticated personalized medicine.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12913
What Are the Latest Innovations Influencing theAcromegaly Market?
Key players in the acromegaly market are investing in the creation of cutting-edge products and services, such as generic lanreotide, to augment the treatment landscape and augment patient results. Generic lanreotide is essentially a non-branded version of the drug used to treat acromegaly and certain neuroendocrine tumours. It serves as a somatostatin analogue, lowering the secretion of growth hormone and thereby expanding patient access to efficient treatment alternatives. For example, in October 2024, Teva Pharmaceutical Industries Ltd., an Israel-based pharmaceutical firm with a focus on generic medications, introduced the inaugural and sole generic variant of Sandostatin LAR Depot in the United States. The injection suspension, known as octreotide acetate, is recommended for the treatment of acromegaly and severe diarrhoea related to carcinoid syndrome. This product launch broadens the reach of vital treatment for patients in need of these therapies.
Who Are the Major Industry Players Accelerating Growth in theAcromegaly Market?
Major companies operating in the acromegaly market are Pfizer Inc., Johnson & Johnson Private Limited, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca PLC, GlaxoSmithKline PLC, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH., Amgen Inc., Allergan Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Ipsen Pharma S.A., Hikma Pharmaceuticals PLC, Lupin Ltd., Recordati S.p.A., Ionis Pharmaceuticals Inc., Amryt Pharma plc, Strongbridge Biopharma PLC, Aquestive Therapeutics Inc., Peptron Inc., Crinetics Pharmaceuticals, Chiasma Inc.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/acromegaly-global-market-report
Which Primary Segments of the Acromegaly Market Are Driving Growth and Industry Transformations?
The acromegaly market covered in this report is segmented –
1) By Type: Ectopic Acromegaly, Acromegaly Due To Growth Hormone
2) By Diagnosis: GH And IGF-I Measurement, Growth Hormone Suppression Test, Imaging, Other Diagnosis
3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations
4) By Treatment: Medication, Somatostatin analogues, Dopamine Agonists, Growth Hormone Antagonist, Surgery, Radiation, Other Treatments
5) By End Users: Hospitals, Specialty Clinics, Homecare, Other End Users
Subsegments:
1) By Ectopic Acromegaly: Tumor-Induced Ectopic Acromegaly, Non-Tumor-Induced Ectopic Acromegaly
2) By Acromegaly Due To Growth Hormone: Primary Growth Hormone Excess, Secondary Growth Hormone Excess
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=12913&type=smp
Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of theAcromegaly Market?# Market?
North America was the largest region in the acromegaly market in 2024. The regions covered in acromegaly market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Reports Similar to the Global Acromegaly Market 2025, By The Business Research Company:
Nerve Repair And Regenerative Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/nerve-repair-and-regenerative-global-market-report
Neurophysiology Devices And Equipment Global Market Report 2024
Generic Central Nervous System Drugs Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
